E

EZZ Life Science Holdings Ltd
ASX:EZZ

Watchlist Manager
EZZ Life Science Holdings Ltd
ASX:EZZ
Watchlist
Price: 3.17 AUD 2.59%
Market Cap: 146.3m AUD
Have any thoughts about
EZZ Life Science Holdings Ltd?
Write Note

EZZ Life Science Holdings Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

EZZ Life Science Holdings Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Revenue
AU$66.4m
CAGR 3-Years
44%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Anteotech Ltd
ASX:ADO
Revenue
AU$514.9k
CAGR 3-Years
-17%
CAGR 5-Years
28%
CAGR 10-Years
5%
Proteomics International Laboratories Ltd
ASX:PIQ
Revenue
AU$1.4m
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
T
Trajan Group Holdings Ltd
ASX:TRJ
Revenue
AU$155m
CAGR 3-Years
27%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Cryosite Ltd
ASX:CTE
Revenue
AU$12.6m
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
3%
Genetic Signatures Ltd
ASX:GSS
Revenue
AU$14.3m
CAGR 3-Years
-21%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

EZZ Life Science Holdings Ltd
Glance View

Market Cap
140.8m AUD
Industry
Life Sciences Tools & Services

EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is wholesale distributor of EAORON skin care products for the Australian and New Zealand markets. The company develops, manufactures and distributes genetic technology enabled consumer health products under its own brand, EZZ. The EAORON brand comprises of five product lines, including Hyaluronic Series, Facial Mask Series, Crystal White Series, Specific Care Series and Anti-Sugar Series. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, wright management and wellbeing, herbal/ traditional and pediatric consumer health products.

EZZ Intrinsic Value
5.04 AUD
Undervaluation 37%
Intrinsic Value
Price
E

See Also

What is EZZ Life Science Holdings Ltd's Revenue?
Revenue
66.4m AUD

Based on the financial report for Jun 30, 2024, EZZ Life Science Holdings Ltd's Revenue amounts to 66.4m AUD.

What is EZZ Life Science Holdings Ltd's Revenue growth rate?
Revenue CAGR 5Y
43%

Over the last year, the Revenue growth was 79%. The average annual Revenue growth rates for EZZ Life Science Holdings Ltd have been 44% over the past three years , 43% over the past five years .

Back to Top